Logo Image

Authors

Brian Nagle, MD

Resident physician, MedStar Georgetown University Hospital, in Washington, DC

Latest Article

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.

Nuri Jacoby, MD
Latest Article

Clinical and Educational Advantages of Simulations in Training the Next Generation of Neurologists: Nuri Jacoby, MD

The neurologist at Maimonides Medical Center and SUNY Downstate shared how interactive simulations give neurology trainees the chance to practice skills, gain feedback, and move beyond passive learning. [WATCH TIME: 3 minutes]

Susan Duberstein, MD
Latest Article

The Transition of Care from Pediatric to Adult Neurology: Leaving the Cocoon

Navigating the transition from pediatric to adult neurology involves careful planning, education, and support to ensure optimal care and independence for young adults.

Gary Owens, MS

Associate director for gene therapy discovery at Precision Biosciences.

Steven Shapiro, MD

Medical Director for Stroke Services at RWJBarnabas Health’s Cooperman Barnabas Medical Center.

Latest Article

Stroke: A Looming Threat for Younger Adults

Steven Shapiro, MD, medical director for Stroke Services at RWJBarnabas Health’s Cooperman Barnabas Medical Center, highlighted some of the reasons why stroke occurs in younger adults under the age of 45 and the risk factors as well as preventative measures this population should be aware of.

Mary Ann Picone, MD, FAAN, FACP
Latest Article

Summer 2024 – Letter From the Editor

Mary Ann Picone, MD, FAAN, FACP, provides a summary of her time at the recently held 2024 CMSC Annual Meeting.

Deena Kuruvilla, MD, FAHS
Latest Article

Chronic Migraine Prevention in Diverse Populations: What the COMPEL Trial Reveals

In this Q&A, migraine expert Deena Kuruvilla, MD, FAAN, provided clinical context on the phase 4 COMPEL trial testing onabotulinumtoxinA as a preventive treatment of chronic migraine in diverse racial groups.

Bijoy E. John, MD

Founder and medical director of Sleep Wellness Clinics of America (Nashville) and Sleep Fix Academy.

Latest Article

Spring Forward or Fall Back: Time-Change Sleep Problems

Bijoy E. John, MD, founder and medical director of Sleep Wellness Clinics of America (Nashville) and Sleep Fix Academy, discussed the health risks associated with daylight saving time changes.

Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences
Latest Article

Questions Linger Around COVID-19’s Origin

Mike Hennessy Sr, Chairman and founder, MJH Life Sciences™, offers his perspective on the questions around the origin of COVID-19 and applauds the extensive efforts to produce vaccines.

Shephard Mpofu, MD

Senior vice president and chief medical officer, Novartis Gene Therapies

Latest Article

Published Phase 3 Data Demonstrates Unprecedented Improvements in SMA Type 1 Compared With Natural History

The senior vice president and chief medical officer at Novartis Gene Therapies shared his perspective on the recent clinical trial results for Zolgensma in SMA type 1.

John Parkinson
Latest Article

CDC and FDA Announce Stroke Safety Concern Related to Pfizer-BioNTech Bivalent COVID-19 Vaccine

Despite previous data suggesting no link, the CDC and FDA will continue to review all evidence for possible increased risk of ischemic stroke.

Elizabeth S. Gromisch, PhD
Latest Article

Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCS

The research neuropsychologist at Mount Sinai Rehabilitation Hospital outlined hallmark patterns of cognitive impairment in multiple sclerosis at the 2026 CMSC Annual Meeting. [WATCH TIME: 6 minutes]

Patrick Strollo, MD, FACP, FCCP, FAASM
Latest Article

Mechanism and Rationale Behind AD109 for Obstructive Sleep Apnea: Patrick Strollo, MD, FACP, FCCP, FAASM

The professor of medicine and clinical translational science at the University of Pittsburgh provided commentary on the mechanism and clinical value of AD109, a novel combination therapy for OSA, following positive phase 3 SynAIRgy trial results. [WATCH TIME: 7 minutes]

Duren M. Ready, MD, FAHS
Latest Article

Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, clinicians have more options than ever to craft a personalized, effective plan for their patients.

Jim Cassidy, MD, PhD

Chief medical officer at SpringWorks Therapeutics.

Latest Article

Potential of Advancing Neurofibromatosis Care With Investigational Mirdametinib

Jim Cassidy, MD, PhD, chief medical officer at SpringWorks Therapeutics, talked about how the prioritization of mirdametinib, a promising treatment for both adult and pediatric patients with neurofibromatosis type 1-associated plexiform neurofibromas.

Diana X. Bharucha-Goebel, MD
Latest Article

Looking Ahead: How Consensus Guidelines Will Shape the Future of SMA Care

This closing episode looks ahead to the future of SMA care, examining how updated best practices aim to accelerate access, optimize outcomes, and fuel ongoing progress.

Kelly King
Latest Article

FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication

The 510(k) clearance was supported by a 3-study, 159-patient registrational program showing a 45.5% increase in response rate vs physical therapy alone, and includes Medicare coverage at launch.

This is where the author name appears
Latest Article

SPONSORED ARTICLE TEMPLATE

This is the deck of the article. It can be used to provide further context to the headline and provides search engines with summary text for social posts.

Gerald McGuire, MD
Caroline Just, MD, FRCPC, CSC-EEG
Latest Article

Rare Diseases Are More Common Than Their Name May Imply

Caroline Just, MD, reflects on the challenges of diagnosing and treating rare neurological diseases, urging for improved education, collaboration, and research efforts.

Adel M. Malek, MD, PhD

Chief, Neurovascular Surgery, and director, Cerebrovascular & Endovascular Division, Tufts University School of Medicine

Latest Article

A New Approach to Communicating Hydrocephalus: An Overdue Opportunity

A pair of cerebrovascular and neurosurgery experts discuss a novel approach to communicating hydrocephalus with an arachnoid granulation using a miniature implant, delivered via a percutaneous endovascular catheter.

Mustafa Saad Siddiqui, MD

Professor of Neurology at Wake Forest School of Medicine

Latest Article

COVID-19 Shutdowns and the Disruption to Deep Brain Stimulation Treatment

While shutdowns disrupted care for all patients with Parkinson disease, hospitals were forced to postpone elective procedures such as the initial DBS device implantation and implantable pulse generator replacements.

Lori Lonczak, MBA, RPh

JET Worldwide Enterprises Inc, in Stony Point, New York

Latest Article

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.

Jessica Yi, MD

Resident, Sidney Kimmel Medical College, Thomas Jefferson University

Latest Article

A Practical Approach to Chronic Immunosuppression in Myasthenia Gravis

A practical approach to initiating and tapering corticosteroids, and the considerations in the selection and monitoring parameters of steroid-sparing agents are crucial to the care of myasthenia gravis.

Sara Hantgan, BSI-C

Bachelor of Science in Information Candidate, University of Michigan

Latest Article

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Kevin Chang, PharmD
Latest Article

Wnt/β-catenin in Multiple Sclerosis: A Nuanced Approach to Remyelination

In this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.

Mark Roskey, PhD
Latest Article

Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD

The chief scientific officer at Quanterix gave a clinical overview on how the company’s Simoa platform enables ultrasensitive detection of neurodegeneration biomarkers in blood, transforming Alzheimer and Parkinson disease research. [WATCH TIME: 3 minutes]

Suketu Khandhar, MD
Latest Article

Filling in the Care Management Gaps for Parkinson Disease With Software Technologies

StrivePD and Apple Watch continuously track motor symptoms, aiding neurologists in adjusting treatments for better patient outcomes.

Emily Spelbrink, MD, PhD
Latest Article

NeuroVoices: Christina Briscoe, MD; Emily Spelbrink, MD, PhD, on Addressing Equity Gaps in Infantile Epileptic Spasms Syndrome

A pair of pediatric epileptologists highlight the systemic and patient level factors driving inequities in infantile epileptic spasms syndrome care and outline paths toward more equitable diagnosis and treatment.

Ashley Alex, MD

University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York

Latest Article

Implementing Headache Training in Residency

Despite a tremendous burden regarding migraine-related disability and expenditure, headache disorders remain underdiagnosed and undertreated, and only a small percentage of patients report satisfaction with the treatment received.